UK Peptide Medicine
Weight loss jabs, pills and peptide medicine, explained without the jargon.
Confused by conflicting advice on Mounjaro, Wegovy and the rest? You’re not alone. Plain English guides for a UK audience, always sourced, always honest.
✓ Always sourced · ✓ UK-focused · ✓ Free to read, always
Most Popular Guides
The guides most readers start with
Start here
Weight Loss Jabs & Pills
Everything you need to know about Mounjaro, Wegovy, Ozempic and the new weight loss pills. How they work, who they’re for, UK access, costs and how they compare.
Updated weekly
Mounjaro UK Price Comparison
Every major UK clinic checked and compared weekly. See exactly what Mounjaro costs before you sign up and find the best price for your dose.
Mounjaro
Mounjaro UK – The Complete Guide
The UK’s most talked-about weight loss injection explained. Costs, side effects, NHS access, maintenance and what results you can realistically expect.
Wegovy
Wegovy UK – The Complete Guide
Wegovy explained: how semaglutide compares to Mounjaro, specialist NHS access, private pricing and what results to expect.
New
Wegovy Pill UK – The Complete Guide
The tablet version of Wegovy, MHRA approved in June 2026. How it works, who it suits and how to access it privately in the UK.
On the horizon
Retatrutide UK – The Next Generation Weight Loss Jab
The treatment many experts believe could outperform Mounjaro. Latest trial results, UK approval timeline and what it means for future weight loss treatment.
New section
Living with weight loss
Practical guides to hair changes, protein, muscle, skin, hydration and tracking while you lose a significant amount of weight.
From the Community
The questions everyone’s asking
The treatments and trends people are talking about in UK forums and groups, checked against the evidence.
Latest Articles
What’s happening in UK peptide medicine
Our Promise
Why readers trust The Peptide Brief
01
Plain English always.
We write about complex science in plain English. No jargon, no Latin, no impenetrable studies. Just clear, honest reporting that anyone can understand and act on.
02
UK focused always.
We cover what matters for a British audience. MHRA regulations, NHS access, UK clinic options and the treatments actually available in this country, not just what works in America.
03
No hype ever.
We say what the evidence supports, what looks promising and what is speculation. We never overstate a study or underplay a risk. Trust is the only thing we have to offer.
Join the Briefing
Weekly. UK-focused.
Every week we break down the latest in GLP-1 weight loss treatments and peptide medicine. Written for a UK audience in plain English. Free to read always.
Free, always. Unsubscribe any time.